Forgot your password?

Forgot your username?

RhinoCyte Biotech Specialty Pharma

201 E. Jefferson, Suite 315
Louisville, KY 40202 USA
Click for website
Research Sector Biotech Specialty Pharma
Summary Description Stem-cell-based diagnostic tools and therapies for the treatment of degenerative neurological diseases such as Parkinson's and Multiple Sclerosis

Click here for Financial Data Keywordsneurology, stl, ALS, parkinsons, multiple sclerosis, spinal cord injury, christopher reeve, stem cells, neurodegenerative


RhinoCyte Inc. is a biotechnology company commercializing autologous adult olfactory-derived stem cell therapies to treat spinal cord injury and neurodegenerative disorders such as Amyotrophic Lateral......view more

Products / Services

According to a standardized procedure the olfactory tissue would be harvested endoscopically by an ENT physician at the patient's site. The tissue will then be shipped to RhinoCyte's Louisville labor......view more

Technology / Differentiation

The core technology involves the biopsy, harvesting, isolation, processing, cryo-preservation and engraftment of adult progenitors into the site of injury. RhinoCyte's lead therapeutic candidate is an...view more

Market / Customers

Spinal cord injury affects more than 250,000 patients in the US alone, with 13,000 new cases annually. According to the National Spinal Cord Injury Statistical Center, annual total costs for spinal co......view more


The company currently seeks Series B funding to develop and commercialize its lead product for spinal cord injuries, specifically to submit an IND and commence phase I trials in 2010....view more